Side-by-side comparison
Abbott Laboratories vs Stryker
As of Sep 25, 2026, P/E is 28.4x for Abbott Laboratories vs 28.2x for Stryker; P/S is 3.9x for Abbott Laboratories vs 4.0x for Stryker; revenue growth is 6.6% for Abbott Laboratories vs 8.5% for Stryker; operating margin is 17.1% for Abbott Laboratories vs 21.4% for Stryker.
Key metrics
| Metric | ABT | SYK |
|---|---|---|
| Price | $101.29 | $272.36 |
| Market cap | $176.43B | $104.47B |
| P/E | 28.4x (#2) | 28.2x (#1) |
| P/S | 3.9x (#1) | 4.0x (#2) |
| Revenue growth | 6.6% (#2) | 8.5% (#1) |
| Operating margin | 17.1% (#2) | 21.4% (#1) |
| Net margin | 13.9% (#2) | 14.4% (#1) |
| Debt / equity | 0.57 (#1) | 0.59 (#2) |
| 1-year return | -24.2% (#1) | -26.2% (#2) |
| Research score | 48/100 (#2) | 56/100 (#1) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Abbott Laboratories (ABT) — Medical Devices
- Stryker Corporation (SYK) — Medical Devices